Literature DB >> 24712980

Plasmablastic lymphoma among human immunodeficiency virus-positive patients: results of a single center's experience.

Chiara Cattaneo1, Alessandro Re, Marco Ungari, Annalisa Peli, Salvatore Casari, Filippo Castelnuovo, Simona Fisogni, Silvia Lonardi, Vilma Pellegrini, Marta Petullà, Fabio Facchetti, Giuseppe Rossi.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24712980     DOI： 10.3109/10428194.2014.911867

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  10 in total

1.  Plasmablastic lymphoma of the maxillary sinus.

Authors:  Ana Isabel Rodrigues; José Cabeçadas; Rita Martins Fernandes; Margarida Viana Coelho; Cristina Sousa
Journal:  Intern Emerg Med       Date:  2019-09-14       Impact factor: 3.397

2.  Immune-checkpoint expression in Epstein-Barr virus positive and negative plasmablastic lymphoma: a clinical and pathological study in 82 patients.

Authors:  Camille Laurent; Bettina Fabiani; Catherine Do; Emmanuelle Tchernonog; Guillaume Cartron; Pauline Gravelle; Nadia Amara; Sandrine Malot; Maryknoll Mawanay Palisoc; Christiane Copie-Bergman; Alexandra Traverse Glehen; Marie-Christine Copin; Pierre Brousset; Stefania Pittaluga; Elaine S Jaffe; Paul Coppo
Journal:  Haematologica       Date:  2016-05-12       Impact factor: 9.941

3.  Primary central nervous system plasmablastic lymphoma in an HIV-positive patient.

Authors:  Ruben Rhoades; Jerald Gong; Neil Palmisiano; Onder Alpdogan
Journal:  BMJ Case Rep       Date:  2019-03-14

4.  Plasmablastic lymphoma is treatable in the HAART era. A 10 year retrospective by the AIDS Malignancy Consortium.

Authors:  Ariela Noy; Shelly Y Lensing; Page C Moore; Neel Gupta; David Aboulafia; Richard Ambinder; Robert Baiocchi; Bruce J Dezube; David Henry; Lawrence Kaplan; Alexandra M Levine; Ronald Mitsuyasu; Lee Ratner; Erin Reid; Scot Remick; Joseph Sparano; Dimitrios Tzachanis; William Wachsman; Amy Chadburn
Journal:  Leuk Lymphoma       Date:  2015-12-16

5.  Stage, age, and EBV status impact outcomes of plasmablastic lymphoma patients: a clinicopathologic analysis of 61 patients.

Authors:  Sanam Loghavi; Khaled Alayed; Tariq N Aladily; Zhuang Zuo; Siok-Bian Ng; Guilin Tang; Shimin Hu; C Cameron Yin; Roberto N Miranda; L Jeffrey Medeiros; Joseph D Khoury
Journal:  J Hematol Oncol       Date:  2015-06-10       Impact factor: 17.388

Review 6.  Current knowledge on HIV-associated Plasmablastic Lymphoma.

Authors:  Michele Bibas; Jorge J Castillo
Journal:  Mediterr J Hematol Infect Dis       Date:  2014-11-01       Impact factor: 2.576

7.  [Clinical characteristics and survival analysis of eight cases HIV-negative plasmablastic lymphoma].

Authors:  X Han; L X Hu; M Q Ouyang; M H Duan; D B Zhou
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2017-04-14

Review 8.  Spanish Lymphoma Group (GELTAMO) guidelines for the diagnosis, staging, treatment, and follow-up of diffuse large B-cell lymphoma.

Authors:  Eva González-Barca; Mónica Coronado; Alejandro Martín; Carlos Montalbán; Santiago Montes-Moreno; Carlos Panizo; Guillermo Rodríguez; Juan Manuel Sancho; Andrés López-Hernández
Journal:  Oncotarget       Date:  2018-08-17

9.  Plasmablastic Lymphoma: A Clinicopathological Study from a Tertiary Care Cancer Center in South India.

Authors:  Manasi C Mundada; Faiq Ahmed; Rachna Khera; Sudha Murthy; Senthil Rajappa; A Santa; Krishnamohan Mallavarapu
Journal:  South Asian J Cancer       Date:  2020-12-14

10.  Bortezomib, Lenalidomide and Dexamethasone Combination Induced Complete Remission in Relapsed/Refractory Plasmablastic Lymphoma: Case Report of a Potential Novel Treatment Approach.

Authors:  Waleed Sabry; Yue Wu; Shruthi Ganeshappa Kodad
Journal:  Curr Oncol       Date:  2022-07-18       Impact factor: 3.109
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.